Category of Chemicals

Bruton's Tyrosine Kinase (BTK) inhibitors are a promising class of drugs used to treat various immune disorders and certain types of cancer, like B-cell malignancies. By inhibiting BTK, these drugs block signaling pathways that contribute to the overactivity of immune cells and the uncontrolled growth of cancer cells. BTK inhibitors have shown great potential in enhancing patient outcomes and expanding treatment options in the field of oncology and immunology.